Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $765.0K | $2.9M |
| Cost of revenue | $350.0K | $639.0K | $1.1M | $789.0K | $3.5M |
| Gross profit | −$350.0K | −$639.0K | −$1.1M | −$24.0K | −$558.0K |
| Gross margin | — | — | — | -3.1% | -19.2% |
| R&D | $10.5M | $21.2M | $32.7M | $46.2M | $47.8M |
| Operating income | −$12.8M | −$27.5M | −$61.3M | −$93.5M | −$102.8M |
| EBITDA | −$12.0M | −$26.6M | −$96.8M | −$84.1M | −$86.5M |
| Net income | −$12.3M | −$28.7M | −$98.9M | −$88.3M | −$94.8M |
| Net margin | — | — | — | -11538.7% | -3257.3% |
| EPS (diluted) | -5.34 | -12.41 | -40.95 | -37.22 | -39.08 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $31M | $-22.14 | $-24.07–$-20.21 | 2 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds OMIC.
No tracked institution reports a position in OMIC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-06-26 | 1-for-30reverse |
No one on the platform has traded OMIC yet.
| $49M |
| — |
| EAREargo, Inc. | $2.57 | -4.10% | $53M | — |
| GCTKGlucoTrack, Inc. | $0.31 | -5.45% | $177046 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$OMIC / Deerfield Management - $OMIC Shareholder Vote
View on StockTwits ↗$OLVI $OMER $OMIC watching closely 🔥 MYNZ +12.86% almost $8 🔥 👀 Petra hinted at a MAJOR U.S. partnership! (Last time she hinted, DGX & TMO PR dropped in 2-3 days) 🚀 Now teasing something even BIGGER! FDA re-submission fast-tracking, U.S. trials ahead, EU expansion growing! Locked in! 😏🔥
View on StockTwits ↗$OMIC how’s OMIC doing on cash? Hear they could be running out of cash but also they could be acquisition target
View on StockTwits ↗@CarefulThoughts A Footnote: Through the last +25Y as an investor, I have never experienced a well-run company like VNDA meet so much resistance in the trading patterns, over such a long period. Even authorities ( which is the main trigger ) act with a weird and non-legal behaviour. I had several investment, where Kevin Tang took a larger pos. Everytime something strange happened. You can check ex. $OMIC and $LITS. Common for all are: Cash higher than Market Cap. I will not be surprised, if Tang is the man behind the curtain here, too.
View on StockTwits ↗$OMIC Singular Genomics Systems, Inc. (NASDAQ:OMIC): Leveraging Novel NGS and Spatial Multiomics Technologies to Empower Researchers and Clinicians https://beyondspx.com/article/singular-genomics-nasdaq-omic-pioneering-spatial-multiomics-for-transformative-research
View on StockTwits ↗$OMIC which one you think? I am leaning the uphill one 30-50 is not a dream
View on StockTwits ↗$OMIC Getting bought for $20/share in the next couple months. This is basically a bond now.
View on StockTwits ↗$OMIC I have no idea why I was able to pick up 500 shares at $19.50 and sell them all at $20 or a few pennies below. Short covering or hostile bid on deck for more than $20? I dunno
View on StockTwits ↗$OMIC I bet Tang is stirring the pot and going to drop an offer after hours. I have a bid under 20.
View on StockTwits ↗$OMIC There is no arbitrage trade here. maybe some short covering or hostile bid brewing. I am out now but omic was good to me. Shenanigans always with these type of friends and family tickers.
View on StockTwits ↗$OMIC what will happen to shares because of this acquisition.
View on StockTwits ↗$OMIC now Deerfield agree to merge or acquire, what stock price next?
View on StockTwits ↗$OMIC https://brodskysmith.com/cases/singular-genomics-systems-inc-nasdaq-omic/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.